IL315333A - A continuous dosing regimen to treat the condition of the eye - Google Patents

A continuous dosing regimen to treat the condition of the eye

Info

Publication number
IL315333A
IL315333A IL315333A IL31533324A IL315333A IL 315333 A IL315333 A IL 315333A IL 315333 A IL315333 A IL 315333A IL 31533324 A IL31533324 A IL 31533324A IL 315333 A IL315333 A IL 315333A
Authority
IL
Israel
Prior art keywords
eye
treatment
condition
dosing regimen
continuous dosing
Prior art date
Application number
IL315333A
Other languages
English (en)
Hebrew (he)
Inventor
Said Saim
Dario Paggiarino
Owen N Durham
Nancy Lurker
Jay S Duker
Michelle Howard-Sparks
Basel Karzoun
Original Assignee
Eyepoint Pharmaceuticals Inc
Said Saim
Dario Paggiarino
Owen N Durham
Nancy Lurker
Jay S Duker
Howard Sparks Michelle
Basel Karzoun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyepoint Pharmaceuticals Inc, Said Saim, Dario Paggiarino, Owen N Durham, Nancy Lurker, Jay S Duker, Howard Sparks Michelle, Basel Karzoun filed Critical Eyepoint Pharmaceuticals Inc
Publication of IL315333A publication Critical patent/IL315333A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL315333A 2022-03-11 2023-03-10 A continuous dosing regimen to treat the condition of the eye IL315333A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263318823P 2022-03-11 2022-03-11
US202263320984P 2022-03-17 2022-03-17
US202263341456P 2022-05-13 2022-05-13
US202263390051P 2022-07-18 2022-07-18
PCT/US2023/064148 WO2023173093A1 (en) 2022-03-11 2023-03-10 Continuous dosing regimen for treatment of a condition of the eye

Publications (1)

Publication Number Publication Date
IL315333A true IL315333A (en) 2024-10-01

Family

ID=85937358

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315333A IL315333A (en) 2022-03-11 2023-03-10 A continuous dosing regimen to treat the condition of the eye

Country Status (9)

Country Link
US (1) US20250186398A1 (https=)
EP (1) EP4489750A1 (https=)
JP (1) JP2025507154A (https=)
KR (1) KR20240156416A (https=)
AU (1) AU2023230976A1 (https=)
CA (1) CA3245209A1 (https=)
IL (1) IL315333A (https=)
TW (1) TW202400143A (https=)
WO (1) WO2023173093A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3886946A1 (en) 2019-06-05 2021-10-06 Regeneron Pharmaceuticals, Inc. Devices and methods for precision dose delivery
AU2021340733A1 (en) * 2020-09-14 2023-05-18 EyePoint Pharmaceuticals, Inc. Bioerodible ocular drug delivery insert and therapeutic method
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2565683T3 (es) 2006-09-15 2016-04-06 Xcovery, Inc. Compuestos inhibidores de quinasa
WO2018059556A1 (zh) 2016-09-29 2018-04-05 贝达药业股份有限公司 激酶抑制剂化合物的多晶型、含其的药物组合物及其制备方法和应用
EP4537830A3 (en) * 2017-06-13 2025-06-11 EyePoint Pharmaceuticals, Inc. Bioerodible drug delivery devices
AU2021340733A1 (en) * 2020-09-14 2023-05-18 EyePoint Pharmaceuticals, Inc. Bioerodible ocular drug delivery insert and therapeutic method

Also Published As

Publication number Publication date
WO2023173093A1 (en) 2023-09-14
KR20240156416A (ko) 2024-10-29
JP2025507154A (ja) 2025-03-13
TW202400143A (zh) 2024-01-01
US20250186398A1 (en) 2025-06-12
CA3245209A1 (en) 2023-09-14
WO2023173093A9 (en) 2023-12-07
EP4489750A1 (en) 2025-01-15
AU2023230976A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
IL315333A (en) A continuous dosing regimen to treat the condition of the eye
LT3681500T (lt) Pilokarpino hidrochlorido naudojimas presbiopijos gydymui
IL289402A (en) A container for a medical device
CA201950S (en) Medicament container
PL4039603T3 (pl) Pojemnik typu wielopak i maszyna do jego produkcji
IL278889A (en) Dosing regimen for the treatment of PI3K-related disorders
LT3952927T (lt) Supakuotų hidrofilinių medicinos produktų, kurie yra hidrinti pakuotėje, gamybos būdai
IL292739B1 (en) Cognitive medical therapies
CA192342S (en) Packaging machine
LT3949971T (lt) Liuteolin-7-o-gliukozido arba liuteolin-7-o-gliukuronido panaudojimas vaisto, skirto akių pažeidimamas gydyti, gamyboje
GB2575304B (en) Medicament packaging arrangements
SMT202400165T1 (it) Regime di dosaggio per agenti anti-bcma
CA187420S (en) Tortilla packaging container
CA232948S (en) Drug package
IL288797A (en) Treatment of synoclinopathy
IL286743A (en) capsule for infusion products
PL3549447T3 (pl) Maszyna do formowania ciasta do wyrobów pieczonych w piekarniku
SG11202112312PA (en) Multilumen body for a medical device
SI4072532T1 (sl) Dozirna oblika za uporabo v zdravljenju ali preprečevanju bolezni
EP4028126C0 (en) TREATMENT OF NEUROLOGICAL DISEASE WITH COMPLEMENT INHIBITORS
IL288972A (en) A continuous process for the preparation of anticholinergic drugs
GB202314366D0 (en) Medical packaging
GB202314365D0 (en) Medical packaging
GB202203093D0 (en) Medicament
GB202310986D0 (en) Medical packaging